Cargando…
AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients
Due to an aging population, assisted-care options are required so that senior citizens may maintain their independence at home for a longer time and rely less on caretakers. Ambient Assisted Living (AAL) encourages the creation of solutions that can help to optimize the environment for senior citize...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689636/ https://www.ncbi.nlm.nih.gov/pubmed/36359582 http://dx.doi.org/10.3390/diagnostics12112739 |
_version_ | 1784836585333719040 |
---|---|
author | Ahmed, Shakeel Naga Srinivasu, Parvathaneni Alhumam, Abdulaziz Alarfaj, Mohammed |
author_facet | Ahmed, Shakeel Naga Srinivasu, Parvathaneni Alhumam, Abdulaziz Alarfaj, Mohammed |
author_sort | Ahmed, Shakeel |
collection | PubMed |
description | Due to an aging population, assisted-care options are required so that senior citizens may maintain their independence at home for a longer time and rely less on caretakers. Ambient Assisted Living (AAL) encourages the creation of solutions that can help to optimize the environment for senior citizens with assistance while greatly reducing their challenges. A framework based on the Internet of Medical Things (IoMT) is used in the current study for the implementation of AAL technology to help patients with Type-2 diabetes. A glucose oxide sensor is used to monitor diabetic elderly people continuously. Spectrogram images are created from the recorded data from the sensor to assess and detect aberrant glucose levels. DenseNet-169 examines and analyzes the spectrogram pictures, and messages are sent to caregivers when aberrant glucose levels are detected. The current work describes both the spectrogram image analysis and the signal-to-spectrogram generating method. The study presents a future perspective model for a mobile application for real-time patient monitoring. Benchmark metrics evaluate the application’s performances, including sensitivity, specificity, accuracy, and F1-score. Several cross--validations are used to evaluate the model’s performance. The findings demonstrate that the proposed model can correctly identify patients with abnormal blood glucose levels. |
format | Online Article Text |
id | pubmed-9689636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96896362022-11-25 AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients Ahmed, Shakeel Naga Srinivasu, Parvathaneni Alhumam, Abdulaziz Alarfaj, Mohammed Diagnostics (Basel) Article Due to an aging population, assisted-care options are required so that senior citizens may maintain their independence at home for a longer time and rely less on caretakers. Ambient Assisted Living (AAL) encourages the creation of solutions that can help to optimize the environment for senior citizens with assistance while greatly reducing their challenges. A framework based on the Internet of Medical Things (IoMT) is used in the current study for the implementation of AAL technology to help patients with Type-2 diabetes. A glucose oxide sensor is used to monitor diabetic elderly people continuously. Spectrogram images are created from the recorded data from the sensor to assess and detect aberrant glucose levels. DenseNet-169 examines and analyzes the spectrogram pictures, and messages are sent to caregivers when aberrant glucose levels are detected. The current work describes both the spectrogram image analysis and the signal-to-spectrogram generating method. The study presents a future perspective model for a mobile application for real-time patient monitoring. Benchmark metrics evaluate the application’s performances, including sensitivity, specificity, accuracy, and F1-score. Several cross--validations are used to evaluate the model’s performance. The findings demonstrate that the proposed model can correctly identify patients with abnormal blood glucose levels. MDPI 2022-11-09 /pmc/articles/PMC9689636/ /pubmed/36359582 http://dx.doi.org/10.3390/diagnostics12112739 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ahmed, Shakeel Naga Srinivasu, Parvathaneni Alhumam, Abdulaziz Alarfaj, Mohammed AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients |
title | AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients |
title_full | AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients |
title_fullStr | AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients |
title_full_unstemmed | AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients |
title_short | AAL and Internet of Medical Things for Monitoring Type-2 Diabetic Patients |
title_sort | aal and internet of medical things for monitoring type-2 diabetic patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689636/ https://www.ncbi.nlm.nih.gov/pubmed/36359582 http://dx.doi.org/10.3390/diagnostics12112739 |
work_keys_str_mv | AT ahmedshakeel aalandinternetofmedicalthingsformonitoringtype2diabeticpatients AT nagasrinivasuparvathaneni aalandinternetofmedicalthingsformonitoringtype2diabeticpatients AT alhumamabdulaziz aalandinternetofmedicalthingsformonitoringtype2diabeticpatients AT alarfajmohammed aalandinternetofmedicalthingsformonitoringtype2diabeticpatients |